<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2011-7293-285-13040</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Innate cellular immunity in the immunopathogenesis of HIV-1 infection in Uganda</narrative>
   <narrative xml:lang="SV">Medf&#xF6;dd cellul&#xE4;r immunitet i HIV infektionens immunopatogenes i Uganda</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="SV">HIV/AIDS har vittg&#xE5;ende effekter i m&#xE5;nga utvecklingsl&#xE4;nder och underminerar anstr&#xE4;ngningarna att utveckla samh&#xE4;llet och reducera fattigdomen. Ett effektivt vaccin &#xE4;r idag ett avl&#xE4;gset m&#xE5;l och f&#xF6;rnyade anstr&#xE4;ngningar f&#xF6;r att f&#xF6;rst&#xE5; HIV infektionens patogenes och immunbiologi &#xE4;r n&#xF6;dv&#xE4;ndiga. Det &#xE4;r viktigt att bygga upp en kunskapsbas och vetenskaplig kompetens inom immunologi i l&#xE4;nder som &#xE4;r v&#xE4;rst drabbade av HIV och de andra stora infektionssjukdomarna. Det h&#xE4;r aktuella projektet handlar om hur celler i m&#xE4;nniskans medf&#xF6;dda (innate) och adaptiva immunsystem fungerar, och hur de agerar och p&#xE5;verkas n&#xE4;r individen blir smittad med virus. Vi &#xE4;r s&#xE4;rskilt intresserade av hur immunsystemet fungerar vid infektion med humant immunbristvirus (HIV). Vi unders&#xF6;ker hur celltyper s&#xE5;som CD8 T celler, naturliga m&#xF6;rdar (NK) celler, samt h&#xF6;gt specialiserade NKT celler svarar p&#xE5; virus, hur de kan skydda, och hur de &#xE4;ven i vissa situationer kan f&#xF6;rv&#xE4;rra sjukdom och bidra till ett snabbare sjukdomsf&#xF6;rlopp. Sammantaget kommer denna forskning att signifikant &#xF6;ka v&#xE5;r f&#xF6;rst&#xE5;else om det adaptiva och det medf&#xF6;dda immunsystemets basala funktion. Samtidigt kommer forskningsresultaten ge &#xF6;kad insikt om varf&#xF6;r det m&#xE4;nskliga immunsystemet inte kan kontrollera infektion med HIV virus, och f&#xF6;rhoppningsvis ge infallsvinklar till nya behandlingsformer vid s&#xE5;v&#xE4;l HIV infektion som andra kroniska infektioner. Projektet bedrivs i huvudsak i Uganda och har en klar m&#xE5;ls&#xE4;ttning att erbjuda forskarutbildning, kunskaps&#xF6;verf&#xF6;ring samt kapacitetsuppbyggande vid v&#xE5;rt samarbetslaboratorie vid Makerere University i Kampala.</narrative>
   <narrative xml:lang="EN">HIV/AIDS has widespread effects in many developing countries and severely undermines efforts for sustainable development and poverty reduction. An effective vaccine remains a distant goal and increased efforts are necessary to understand the pathogenesis and potential immune correlates of protection against infection and disease progression. Additionally, it is incumbent upon researchers to build capacity in immunology in those resource limited countries most affected by HIV-1 and other infectious diseases. In this project, we will work towards these goals by investigating our preliminary findings concerning: (1) defects in natural killer (NK) cell responses in HIV infected Ugandans; (2) involvement of invariant NKT cells in the differential pathogenicity of HIV clade A and D infections; and (3) development of innate NK-like functions in CD8 T cells in HIV infected Ugandans. This is a collaborative effort between the Center for Infection Medicine at Karolinska Institutet and the Makerere University Walter Reed Project in Kampala, Uganda. The project involves an exchange of research visits between the MU and KI laboratories, and research training of a Ugandan PhD-student in the KI PhD program in Infection Biology. We anticipate that these investigations will significantly enhance our understanding of the role of innate cellular immunity in HIV-1 infection, and facilitate technology transfer and contribute strongly to research capacity building at the MU laboratories.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Karolinska Institutet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="4"></activity-status>
  <activity-date iso-date="2012-01-01" type="2"></activity-date>
  <activity-date iso-date="2014-12-31" type="4"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="UG" percentage="100">
   <narrative xml:lang="EN">Uganda</narrative>
  </recipient-country>
  <sector code="130" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Population Policies/Programmes &amp; Reproductive Health</narrative>
  </sector>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
  </sector>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2013-01-01"></period-start>
   <period-end iso-date="2013-12-28"></period-end>
   <value currency="USD" value-date="2013-01-01">35773.5061106676</value>
  </budget>
  <budget>
   <period-start iso-date="2014-01-01"></period-start>
   <period-end iso-date="2014-12-28"></period-end>
   <value currency="USD" value-date="2014-01-01">33965.5097013076</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2011-11-15"></transaction-date>
   <value currency="USD" value-date="2011-11-15">107717.4382050176</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2014-01-28"></transaction-date>
   <value currency="USD" value-date="2014-01-28">33965.5097013076</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
